PTC Therapeutics
PTCT
PTCT
171 hedge funds and large institutions have $2.37B invested in PTC Therapeutics in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 71 increasing their positions, 55 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6.12% more ownership
Funds ownership: 107.68% → 113.8% (+6.1%)
3% less funds holding
Funds holding: 177 → 171 (-6)
10% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 29
Holders
171
Holding in Top 10
4
Calls
$11.8M
Puts
$3.38M
Top Buyers
| 1 | +$80.6M | |
| 2 | +$56.7M | |
| 3 | +$40.4M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$24.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.6M |
Top Sellers
| 1 | -$183M | |
| 2 | -$48.1M | |
| 3 | -$17.4M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$15.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$12.7M |